The immunosuppressant drugs market in the UK is expected to reach a projected revenue of US$ 10,167.1 million by 2027. A compound annual growth rate of 6.9% is expected of the UK immunosuppressant drugs market from 2021 to 2027.
In terms of revenue, UK accounted for 6.6% of the global immunosuppressant drugs market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
In Europe, Germany immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
UK is the fastest growing regional market in Europe and is projected to reach USD 10,167.1 million by 2027.
Dental care in the United Kingdom is routinely provided by the National Health Service, however, due to the large waiting lists and rising costs, more individuals are willing to pay for private care. The NHS in England spends around £3.4bn per year on dental services. Many individuals in the UK are deterred from visiting the dentist due to the cost of treatment.
Most people opt for private treatment as NHS does not cover the cost of aesthetic dentistry treatments. According to a report published by Dentistry online, growing number of people under the age of 34 in UK are opting to visit a dentist for cosmetic procedures rather than repeated checkups. Moreover, half of people aged 18 to 34 have had teeth whitening treatments in 2018.
Almost one in four (17%) adults in the UK stated that stained teeth would negatively affect their self-confidence and believed it is a sign of poor hygiene. According to Quality Watch which is a research program to examine the quality of health and social care, between 2015- 2016, 20 million dental examinations, 5, 50000 radiographs and 5, 25000 permanent filling & sealant restorations were carried out by NHS.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 73.78% in 2020.
Horizon Databook has segmented the U.K. immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
Dental care in the United Kingdom is routinely provided by the National Health Service, however, due to the large waiting lists and rising costs, more individuals are willing to pay for private care. The NHS in England spends around £3.4bn per year on dental services. Many individuals in the UK are deterred from visiting the dentist due to the cost of treatment.
Most people opt for private treatment as NHS does not cover the cost of aesthetic dentistry treatments. According to a report published by Dentistry online, growing number of people under the age of 34 in UK are opting to visit a dentist for cosmetic procedures rather than repeated checkups. Moreover, half of people aged 18 to 34 have had teeth whitening treatments in 2018.
Almost one in four (17%) adults in the UK stated that stained teeth would negatively affect their self-confidence and believed it is a sign of poor hygiene. According to Quality Watch which is a research program to examine the quality of health and social care, between 2015- 2016, 20 million dental examinations, 5, 50000 radiographs and 5, 25000 permanent filling & sealant restorations were carried out by NHS.
U.K. Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
Calcineurin Inhibitors
mTOR Inhibitors
Antiproliferative Agents
Monoclonal Antibodies
Others
U.K. Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
Autoimmune Diseases
Organ Transplants
Other Applications
U.K. Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
Oral
Injectables
U.K. Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Reasons to subscribe to Immunosuppressant Drugs Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Immunosuppressant Drugs Market databook
Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into U.K. Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.